Clinical Trial Update: DuoTrav® Eye Drops As Replacement Therapy Program [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating DuoTrav as a replacement therapy for open-angle glaucoma and ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• DuoTrav (travoprost; timolol (fixed-dose combination))

Snippet

Sponsor: Alcon Research | Conditions: Open-angle Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED